| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 142.60B | 145.46B | 142.25B | 135.05B | 131.71B | 114.13B |
| Gross Profit | 37.39B | 38.41B | 36.53B | 35.25B | 29.09B | 29.06B |
| EBITDA | 15.63B | 15.89B | 15.27B | 16.62B | 10.82B | 11.09B |
| Net Income | 5.79B | 6.60B | 5.07B | 6.39B | 2.53B | 2.89B |
Balance Sheet | ||||||
| Total Assets | 160.53B | 164.85B | 153.94B | 151.60B | 144.53B | 134.53B |
| Cash, Cash Equivalents and Short-Term Investments | 16.62B | 19.31B | 17.46B | 19.45B | 18.50B | 16.19B |
| Total Debt | 23.24B | 24.41B | 24.11B | 24.63B | 24.51B | 20.71B |
| Total Liabilities | 51.98B | 51.33B | 48.08B | 51.53B | 48.40B | 44.29B |
| Stockholders Equity | 103.80B | 108.63B | 101.03B | 95.28B | 91.71B | 86.00B |
Cash Flow | ||||||
| Free Cash Flow | 2.58B | 5.94B | 712.00M | 8.89B | 525.00M | 314.00M |
| Operating Cash Flow | 12.14B | 16.35B | 8.90B | 15.66B | 8.72B | 5.97B |
| Investing Cash Flow | -8.06B | -8.57B | -8.61B | -8.06B | -6.48B | -5.89B |
| Financing Cash Flow | -3.83B | -3.75B | -3.83B | -8.45B | 1.02B | -2.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥435.88B | 10.13 | 6.90% | 2.71% | 1.04% | 110.81% | |
76 Outperform | ¥13.81B | 8.51 | ― | 1.20% | 2.32% | -10.75% | |
74 Outperform | ¥76.67B | 12.05 | ― | 6.64% | 1.64% | -3.80% | |
70 Outperform | ¥135.57B | 4.25 | 10.46% | 2.35% | 2.18% | 84.02% | |
69 Neutral | ¥56.63B | 9.03 | ― | 3.31% | 2.25% | 30.32% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥18.55B | 21.58 | ― | 4.39% | 2.82% | -16.49% |